Decision ruleSurgery

UCLA Integrated Staging System for renal cell carcinoma (UISS)

Classifies risk after nephrectomy by combining TNM stage, Fuhrman grade and ECOG performance status.

Updated 30 October 2026

When to use it

Patients with renal cell carcinoma after nephrectomy, for prognosis, follow-up planning and adjuvant trial selection.

What it needs

  • T (1997 TNM)Options: T1: ≤ 7 cm, confined to the kidney · T2: > 7 cm, confined to the kidney · T3: adrenal or perinephric fat, renal vein or vena cava · T4: beyond Gerota's fascia
  • N (1997 TNM)Options: N0: no nodal metastases · N1: single regional node · N2: more than one regional node
  • Distant metastasis (M)Options: M0: none · M1: present
  • Fuhrman nuclear gradeOptions: 1 · 2 · 3 · 4
  • ECOG performance statusOptions: 0 · ≥ 1

The points for each answer and the automatic total are in the app.

How to interpret it

UISS risk group
ResultInterpretation
≤ 1Localised disease: low risk
2Localised disease: intermediate risk
3Localised disease: high risk
11Metastatic disease: low risk
12Metastatic disease: intermediate risk
≥ 13Metastatic disease: high risk

Practical tip

It uses 1997 TNM, in which adrenal invasion was T3a; contiguous adrenal invasion is now T4.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top